Search

Copyright of MN Opthalmology / MN Oftalmoloji is the property of Medical Network and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Turkish Journal of Trauma & Emergency Surgery / Ulusal Travma ve Acil Cerrahi Dergisi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Turkish Bulletin of Hygiene & Experimental Biology / Türk Hijyen ve Deneysel Biyoloji is the property of Refik Saydam National Public Health Agency and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Purpose: The aim of this study is to observe and compare effects of 4 mg/0.1 ml intravitreal and 20 mg/0.5 ml subtenon triamcinolone acetonide treatment to intraocular pressure (IOP) and lens, applied for inflammation caused by posterior and intermediate uveitis with different etiologies. Materials And Methods: The records for 86 eyes of 69 patients being treated for posterior and intermediate uveitis were evaluated on this retrospective study. 42 patients were treated with intravitreal (IVTA) and 44 patients treated with subtenon triamcinolone (PSTA). Clinic follow-up observations were made on 4 control periods; first control period was i day, second control period was 1 month, third control period was 3 months and fourth control period was 6 months after injection. During control examinations, intraocular pressures were measured with applanation tonometer and complications for increased lens densities were recorded. Results: Average intraocular eye pressure levels for intravitreal and posterior subtenon patients were measured as 14.12±1.53 and 14.43±1.85 respectively first day after injection, 23.71±5.20 and 18,41±4.05 at the end of first month after injection, 15.57±2.99 and 15.29±2.31 at the end of third month after injection and 15.05±2,06 and 15.30±2.31 at the end of sixth month after injection. When the results were compared at the end of first month, significant difference between the groups was observed (p<0.05). IOP was clearly increased on IVTA group. However IOP increase on following examinations were not significantly different (p>0.05). Cataract progression or existing opacity increase after IVTA and PSTA injections were observed as 9 (21.4%) on IVTA group and 8 (18.2%) on PSTA group and the difference was not significant (p>0.05). Conclusion: Although intraocular pressure at the end of first month was higher on IVTA group, no difference was observed on later examinations. [ABSTRACT FROM AUTHOR]

Purpose: The purpose of this study is to investigate efficiency and complications of posterior subtenon triamcinolone (PSTT) injection for treatment of uveits. Materials and Methods: 40 eyes of 22 patients, which were diagnosed with uveit and treated with PSTT in our clinic, are included in this study. Before and after PSTT treatment visual acuity on 1st, 3rd and 6th months, complications such as vitritis, retinal vasculitis or changes in cystoid macular oedema (CMO), increase in intraocular pressure (IOP) and cataract progression were recorded. Success of treatment was evaluated with clinic and angiographic regression for CMO and vasculitis. Vitritis was followed with biomicroscobic examination. Wilcoxon test was used for statistical analysis. Results: 40 eyes of 22 patients were followed for average 18.2 months (6-21 months). Included patient in study; Grup A: Idiopathic, Grup B: Behçet, Grup C: Pars planit for üveitis. When results were examined, PSTT efficiency found; CMO was observed in 40% of the patients at the beginning and was observed 20% in the 1st month, 20% in the 3rd month and 10% in the 6th month, vitritis was observed in 100% of the patients at the beginning and was observed 10% in the 1st month, 10% in the 3rd month and 0% in the 6th month and vasculitis was observed in 10% of the patients at the beginning and was observed 0% in the 1st month for Group A. CMO was observed in 60% of the patients at the beginning and was observed 40% in the 1st month, 30% in the 3rd month and 30% in the 6th month, vitritis was observed in 90% of the patients at the beginning and was observed 40% in the 1st month, 0% in the 3rd month and vasculitis was observed in 10% of the patients at the beginning and was observed 10% in the 1st month and 0% in the 3rd month for Group B. CMO was observed in 50% of the patients at the beginning and was observed 0% in the 1st month and vitritis was observed in 100% of the patients at the beginning and was observed 0% in the 1st month, for Group C. The effect of PSTT treatment on visual acuity was; 0.36 at the beginning and 0.48, 0.50, 0.49 at the 1st 3rd and 6th months respectively for Group A, 0.53 at the beginning and 0.60, 0.56, 0.56 at the 1st 3rd and 6th months respectively for Group B and 0.40 at the beginning and 0.48, 0.49, 0.49 at the 1st 3rd and 6th months respectively for Group C. During the follow-up period intraocular pressure was observed over 21mmHg on 2 eyes (5%). With topical antiglaucoma treatment, IOP was taken under control. On 3 eyes (7.5%) cataract progression was observed. Conclusion: PSTT treatment is found effective to contain posterior segment inflammation of uveits. [ABSTRACT FROM AUTHOR]

Objective: To compare the the results of external dacryocystorhinostomy using double flaps anastomosis and single flaps anastomosis Methods: Fifty-one eyes of 48 consecutive patients with complain epiphora and chronic dacryocystitis who had undergone external dacryocystorhinostomy from October 2009 to January 2012 were included. Single flap anastomosis were performed on 26 eyes of 26 patients and double flaps anastomosis were performed on 25 eyes of 22 patients and reviewed surgical success rate. Results: Silicon tube intubations were performed on 13 eyes with single flaps anastomosis and 20 eyes with double flaps anastomosis. The mean length of follow-up was 16.2±1.3 months for single flaps anastomosis group and 18.1±2.1 months for double flaps anastomosis group. Success rates in single flap anastomosis group and double flaps anastomosis group were 92.4% and 96%, respectively. There was no statistically significant difference in success rate between the groups (p=0.088). Conclusion: Single flap and double flap anastomosis gave similar outcome in external dacryocystorhinostomy surgery. [ABSTRACT FROM AUTHOR]

Background: To evaluate the results of penetrating keratoplasty (PK) due to trauma-related corneal scarring., Methods: We evaluated 24 eyes of 24 patients who underwent PK due to trauma-related scarring of the cornea between May 2010 and June 2016. The postoperative visual acuity, graft transparency, and complications were evaluated., Results: The patients were divided into two groups. In group 1, 14 eyes of patients with traumatic corneal scars and retinal detachment underwent PK, pars plana vitrectomy, and intravitreal silicone administration with the help of temporary keratoprosthesis. Group I included five females and nine males with an average age of 39.15+-13.32 (min 8-max 73) years. An intraocular foreign body was removed from five of the eyes. The mean visual acuity was 3.01+-0.013 (3.10-1.00) logMAR after the surgery, 1.36+-0.23 (3.10-0.80) at the postoperative first month, and 1.18+-0.03 (3.10-0.70) at the end of the first year after the removal of keratoplasty sutures. During the follow-up of patients, two eyes (14.2%) lost light sensation, eight eyes (57.1%) developed postoperative glaucoma, nine eyes (64.2%) had graft rejection, and one patient (7.1%) developed keratitis. In one eye (7.1%), the cornea was scraped using ethylenediaminetetraacetic acid due to silicone-related band keratopathy. In group 2, ten eyes with trauma-related corneal scars underwent PK. This group included two females and eight males with an average age of 29.23+-12.03 (11-63) years. The mean visual acuity was 2.98+-0.68 (3.10-1.00) logMAR before the surgery, 0.58+-0.22 (1.80-0.30) at the postoperative first month, and 0.50+-0.17 (1.80-0.10) at the end of the first year. One eye (10%) with iridodialysis developed glaucoma. Rejection was not seen in any of the patients. A statistically significant difference was observed in both groups with regard to visual acuity before operation, at 1 and 12 months after operation, and at 12 months for graft transparency rates (p=0.015, p=0.021, p=0.001, respectively)., Conclusion: In cases of eye injuries due to trauma, the eyes subjected to combined vitrectomy and PK had poor visual prognosis and high graft rejection rate compared to those subjected to PK as the only treatment.